The US Food and Drug Administration (FDA) has identified a limited number of benzoyl peroxide (BPO) acne products for retail-level recall because of elevated benzene levels, but more than 90% of tested products have very low or undetectable benzene levels, according to an FDA statement. The agency conducted independent testing on 95 benzoyl peroxide acne […]
The post FDA Confirms Low Benzene Levels in Most BPO Products Tested first appeared on News Health.
Author : News Health
Publish date : 2025-03-18 12:06:00
Copyright for syndicated content belongs to the linked Source.